Global Dermatology OTC Medications Market Insights, Forecast to 2025

Global Dermatology OTC Medications Market Insights, Forecast to 2025

Summary

This report studies the global market size of Dermatology OTC Medications in key regions like North America, Europe, Asia Pacific, Central & South America and the Middle East & Africa, focuses on the consumption of Dermatology OTC Medications in these regions.

This research report categorizes the global Dermatology OTC Medications market by top players/brands, region, type and end user. This report also studies the global Dermatology OTC Medications market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

In 2018, the global Dermatology OTC Medications market size was increased to 11675 million US$ from 10343 million US$ in 2014, and it will reach 14530 million US$ in 2025, growing at CAGR of 3.25% between 2019 and 2025.

The objectives of this study are to define, segment, and project the size of the Dermatology OTC Medications market based on company, product type, end-user and key regions.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bayer
GSK
Teva
Johnson & Johnson
Novartis
Mylan
Sun Pharmaceutical
Aurobindo
Galderma
CR SANJIU
Dr. Reddy's
Lupin
Bausch Health
Cipla
Qilu Pharmaceutical
Almirall
Lingrui

Dermatology OTC Medications market size by type:
External Use
Oral

Dermatology OTC Medications market size by Applications:
Hospital
Drug Store
Other

Dermatology OTC Medications market size by region
North America
United States
Canada
Mexico

Asia-Pacific
China
Japan
South Korea
India
Australia
Southeast Asia

Europe
Germany
France
UK
Italy
Russia
Rest of Europe

Central & South America
Brazil
Argentina
Rest of Central & South America

Middle East & Africa
Africa
Middle East


1 Study Coverage
1.1 Dermatology OTC Medications Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Dermatology OTC Medications Market Size Growth Rate by Type
1.4.2 External Use
1.4.3 Oral
1.5 Market by Application
1.5.1 Global Dermatology OTC Medications Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Drug Store
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Dermatology OTC Medications Market Size
2.1.1 Global Dermatology OTC Medications Revenue 2014-2025
2.1.2 Global Dermatology OTC Medications Sales 2014-2025
2.2 Dermatology OTC Medications Growth Rate by Region
2.2.1 Global Dermatology OTC Medications Sales by Region
2.2.2 Global Dermatology OTC Medications Revenue by Region
3 Breakdown Data by Manufacturer
3.1 Dermatology OTC Medications Sales by Manufacturer
3.1.1 Dermatology OTC Medications Sales by Manufacturer
3.1.2 Dermatology OTC Medications Sales Market Share by Manufacturer
3.2 Dermatology OTC Medications Revenue by Manufacturer
3.2.1 Dermatology OTC Medications Revenue by Manufacturer (2018-2019)
3.2.2 Dermatology OTC Medications Revenue Share by Manufacturer (2018-2019)
3.2.3 Global Market Concentration Ratio (CR5 and HHI)
3.3 Dermatology OTC Medications Price by Manufacturer
3.4 Dermatology OTC Medications Manufacturing Base Distribution, Product Types
3.4.1 Dermatology OTC Medications Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dermatology OTC Medications Product Type
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Dermatology OTC Medications Sales by Type
4.2 Global Dermatology OTC Medications Revenue by Type
4.3 Dermatology OTC Medications Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Dermatology OTC Medications Breakdown Data by Application
6 North America
6.1 North America Dermatology OTC Medications by Country
6.1.1 North America Dermatology OTC Medications Sales by Country
6.1.2 North America Dermatology OTC Medications Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Dermatology OTC Medications by Type
6.3 North America Dermatology OTC Medications by Application
7 Europe
7.1 Europe Dermatology OTC Medications by Country
7.1.1 Europe Dermatology OTC Medications Sales by Country
7.1.2 Europe Dermatology OTC Medications Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Dermatology OTC Medications by Type
7.3 Europe Dermatology OTC Medications by Application
8 Asia Pacific
8.1 Asia Pacific Dermatology OTC Medications by Country
8.1.1 Asia Pacific Dermatology OTC Medications Sales by Country
8.1.2 Asia Pacific Dermatology OTC Medications Revenue by Country
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Southeast Asia
8.2 Asia Pacific Dermatology OTC Medications by Type
8.3 Asia Pacific Dermatology OTC Medications by Application
9 Central & South America
9.1 Central & South America Dermatology OTC Medications by Country
9.1.1 Central & South America Dermatology OTC Medications Sales by Country
9.1.2 Central & South America Dermatology OTC Medications Revenue by Country
9.1.3 Brazil
9.1.4 Argentina
9.2 Central & South America Dermatology OTC Medications by Type
9.3 Central & South America Dermatology OTC Medications by Application
10 Middle East and Africa
10.1 Middle East and Africa Dermatology OTC Medications by Country
10.1.1 Middle East and Africa Dermatology OTC Medications Sales by Country
10.1.2 Middle East and Africa Dermatology OTC Medications Revenue by Country
10.1.3 Middle East
10.1.4 Africa
10.2 Middle East and Africa Dermatology OTC Medications by Type
10.3 Middle East and Africa Dermatology OTC Medications by Application
11 Analysis of Dermatology OTC Medications Industry Key Manufacturers
11.1 Bayer
11.1.1 Company Profile
11.1.2 Product Information
11.1.3 Sales, Price and Revenue
11.2 GSK
11.2.1 Company Profile
11.2.2 Product Information
11.2.3 Sales, Price and Revenue
11.3 Teva
11.3.1 Company Profile
11.3.2 Product Information
11.3.3 Sales, Price and Revenue
11.4 Johnson & Johnson
11.4.1 Company Profile
11.4.2 Product Information
11.4.3 Sales, Price and Revenue
11.5 Novartis
11.5.1 Company Profile
11.5.2 Product Information
11.5.3 Sales, Price and Revenue
11.6 Mylan
11.6.1 Company Profile
11.6.2 Product Information
11.6.3 Sales, Price and Revenue
11.7 Sun Pharmaceutical
11.7.1 Company Profile
11.7.2 Product Information
11.7.3 Sales, Price and Revenue
11.8 Aurobindo
11.8.1 Company Profile
11.8.2 Product Information
11.8.3 Sales, Price and Revenue
11.9 Galderma
11.9.1 Company Profile
11.9.2 Product Information
11.9.3 Sales, Price and Revenue
11.10 CR SANJIU
11.10.1 Company Profile
11.10.2 Product Information
11.10.3 Sales, Price and Revenue
11.11 Dr. Reddy’s
11.11.1 Company Profile
11.11.2 Product Information
11.11.3 Sales, Price and Revenue
11.12 Lupin
11.12.1 Company Profile
11.12.2 Product Information
11.12.3 Sales, Price and Revenue
11.13 Bausch Health
11.13.1 Company Profile
11.13.2 Product Information
11.13.3 Sales, Price and Revenue
11.14 Cipla
11.14.1 Company Profile
11.14.2 Product Information
11.14.3 Sales, Price and Revenue
11.15 Qilu Pharmaceutical
11.15.1 Company Profile
11.15.2 Product Information
11.15.3 Sales, Price and Revenue
11.16 Almirall
11.16.1 Company Profile
11.16.2 Product Information
11.16.3 Sales, Price and Revenue
11.17 Lingrui
11.17.1 Company Profile
11.17.2 Product Information
11.17.3 Sales, Price and Revenue
12 Future Forecast
12.1 Dermatology OTC Medications Market Forecast by Region
12.1.1 Global Dermatology OTC Medications Sales Forecast by Region 2020-2025
12.1.2 Global Dermatology OTC Medications Revenue Forecast by Region 2020-2025
12.2 Dermatology OTC Medications Market Forecast by Type
12.2.1 Global Dermatology OTC Medications Sales Forecast by Type (2020-2025)
12.2.2 Global Dermatology OTC Medications Revenue Forecast by Type (2020-2025)
12.3 Dermatology OTC Medications Market Forecast by Application
12.4 North America Dermatology OTC Medications Forecast
12.5 Europe Dermatology OTC Medications Forecast
12.6 Asia Pacific Dermatology OTC Medications Forecast
12.7 Central & South America Dermatology OTC Medications Forecast
12.8 Middle East and Africa Dermatology OTC Medications Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Trends
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Dermatology OTC Medications Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Dermatology OTC Medications Product Picture
Table Dermatology OTC Medications Market Segments
Table Key Manufacturers of Dermatology OTC Medications Covered in 2018
Table Global Dermatology OTC Medications Market Size Growth Rate by Type (2020-2025) (M Unit) & (M USD)
Figure Global Dermatology OTC Medications Sales Market Share by Type in 2018
Figure Global Dermatology OTC Medications Sales Market Share by Type in 2025
Table Classification of Dermatology OTC Medications
Figure External Use Product Picture
Figure Oral Product Picture
Table Global Dermatology OTC Medications Market Size Growth Rate by Application (2020-2025) (M Unit)
Figure Global Dermatology OTC Medications Sales Market Share by Application in 2018
Table Applications of Dermatology OTC Medications
Figure Hospital
Figure Drug Store
Figure Dermatology OTC Medications Report Years Considered
Figure Global Dermatology OTC Medications Market Size 2014-2025 (M USD)
Figure Global Dermatology OTC Medications Sales 2014-2025 (M Unit)
Table Global Dermatology OTC Medications Market Size by Region 2014-2019 (M Unit) & (M USD)
Figure Global Dermatology OTC Medications Market Share by Regions 2018
Table Global Dermatology OTC Medications Sales by Region 2014-2019 (M Unit)
Table Global Dermatology OTC Medications Sales Market Share by Region 2014-2019
Figure Global Dermatology OTC Medications Sales Market Share by Region 2014-2019
Figure Global Dermatology OTC Medications Sales Market Share by Region in 2018
Table Global Dermatology OTC Medications Revenue by Region 2014-2019 (M USD)
Figure Global Dermatology OTC Medications Revenue Market Share by Region 2014-2019
Figure Global Dermatology OTC Medications Revenue Market Share by Region in 2018
Table Global Dermatology OTC Medications Sales by Manufacturer (2018-2019) (M Unit)
Table Global Dermatology OTC Medications Sales Share by Manufacturer (2018-2019)
Figure Global Dermatology OTC Medications Sales Share by Manufacturer in 2018
Table Dermatology OTC Medications Revenue by Manufacturer (2018-2019) (M USD)
Table Dermatology OTC Medications Revenue Share by Manufacturer (2018-2019)
Figure Dermatology OTC Medications Revenue Share by Manufacturer in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Dermatology OTC Medications Price (2018-2019) (USD/Unit)
Table Dermatology OTC Medications Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Dermatology OTC Medications Product Type
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Dermatology OTC Medications Sales by Type (2014-2019) (M Unit)
Table Global Dermatology OTC Medications Sales Share by Type (2014-2019)
Figure Global Dermatology OTC Medications Sales Market Share by Type (2014-2019)
Figure Global Dermatology OTC Medications Sales Market Share by Type in 2018
Table Global Dermatology OTC Medications Revenue by Type (2014-2019) (M USD)
Table Global Dermatology OTC Medications Revenue Share by Type (2014-2019)
Figure Global Dermatology OTC Medications Revenue Market Share by Type (2014-2019)
Figure Global Dermatology OTC Medications Revenue Market Share by Type in 2018
Table Dermatology OTC Medications Price by Type (2014-2019) (USD/Unit)
Table Global Dermatology OTC Medications Market Size Growth Rate by Application (2020-2025) (M Unit)
Table Global Dermatology OTC Medications Sales by Application (2014-2019) (M Unit)
Table Global Dermatology OTC Medications Sales Share by Application (2014-2019)
Figure Global Dermatology OTC Medications Market Share by Application (2014-2019)
Figure Global Dermatology OTC Medications Market Share by Application in 2018
Figure North America Dermatology OTC Medications Sales Growth Rate 2014-2019 (M Unit)
Figure North America Dermatology OTC Medications Revenue Growth Rate 2014-2019 (M USD)
Table North America Dermatology OTC Medications Sales by Country (2014-2019) (M Unit)
Table North America Dermatology OTC Medications Sales Market Share by Country (2014-2019)
Figure North America Dermatology OTC Medications Sales Market Share by Country in 2018
Table North America Dermatology OTC Medications Revenue by Country (2014-2019) (M USD)
Table North America Dermatology OTC Medications Revenue Market Share by Country (2014-2019) 35

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook